Belbel Caesar J

Avg. Two Year Performance

No purchase track record
54% Avg. Sale Return
24% Compound
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return----------
Purchase Success Rate----------
Average Sale Return32%44%45%49%54%
Sale Success Rate3 of 33 of 33 of 33 of 32 of 3
Drugs » Biotechnology

EVP, Chief Legal Officer:

Holdings: 0 shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--
Drugs » Biotechnology

COO, CLO, and Secretary:

Holdings: 207.43K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--